GenMark Expects 7 Percent Revenue Growth for Q4
Jan 9, 2018 @ 8:25

The company attributed the revenue increase to strong sales of its ePlex molecular diagnostics systems.

Sourced through Scoop.it from: www.genomeweb.com

Leave a Reply